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ABSTRACT – Pigmented epithelioid melanocytoma is a rare, newly described melanocytic tumor that encompasses lesions previously classified 
as animal type melanomas and epithelioid blue nevus of the Carney complex. Pigmented epithelioid melanocytoma is a specific clinicopatho-
logical entity with particular clinical presentation and histological features. We present the case of a 5 year old female patient with a heavily 
pigmented papule on her right thigh that showed histological findings compatible with pigmented epithelioid melanocytoma and discuss the 
relevance /clinical significance of sentinel lymph node biopsy as a staging procedure in this particular neoplasm.  
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RESUMO – Melanocitoma epitelioide pigmentado é um tumor raro, recentemente descrito que engloba lesões previamente classificadas como 
melanomas “tipo animal” e nevo azul epitelioide do complexo de Carney. Melanocitoma epitelioide pigmentado é uma entidade clinicohistopa-
tológica específica com apresentação clínica e características histopatológicas particulares. Apresentaremos o caso de uma paciente do sexo 
feminino de 5 anos de idade com uma pápula densamente pigmentada em sua coxa direita que mostrou achados histológicos compatíveis com 
Melanocitoma epitelioide pigmentado e discutiremos a relevância/ significância clínica da biópsia de linfonodo sentinela como parte do processo 
de estadiamento dessa neoplasia em particular. 
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INTRODUCTION
Pigmented epithelioid melanocytoma (PEM) is a rare melano-
cytic tumor composed of pigmented epithelioid and dendritic me-
lanocytes with large nuclei.1 This histologic entity encompasses 
tumors previously described as epithelioid blue nevus of the Carney 
complex2,3 and "animal-type melanomas".2,4
Clinically, it presents as a slowly growing, densely pigmented 
papule or nodule on extremities, trunk and head.1 This tumor is 
more common in young adults and children but can occur at any 
age.2
Most cases are sporadic1 and a small subset of cases is asso-
ciated with the Carney complex.2 Carney’s complex is a familial 
syndrome characterized by blue naevi, lentigines, myxomas and 
rare tumors such as psammomatous melanotic schwannoma.3
Histological findings of PEM include: wedge-shaped symme-
trical configuration; central increased cellularity; epithelioid cells, 
dendritic cells and melanophages.1 Clusters of large multinuclea-
ted cells with vesicular nuclei and macronucleoli (Reed-Sternberg-
-like) are the most distinct finding in PEM.1
The treatment comprises of simple excision. Although Ludgate 
et al and Zembowics et al reported a positive sentinel lymph node 
biopsy (SLNB), respectively in 47%5 and 46%,2 there is no evidence 
to recommend that sentinel lymph node sampling in primary cuta-
neous PEM has therapeutic or prognostic value.1
This case report describes the diagnosis of PEM in a 5-year-
-old patient presenting with classic clinical features and compatible 
histological findings.
Case Report
The patient is a female 5-year-old from Campo Grande in the 
state of Mato Grosso do Sul, Brazil. At a Dermatology consultation 
her mother expressed concern over a dark papule that had appea-
red on her daughter's right thigh 2 years prior and was slowly 
growing in size. The lesion was asymptomatic. No palpable lymph 
node was noted.  There was no history of frequent sun exposure.
The patient had no prior medical conditions, was not using any 
medication and had never undergone any skin biopsy procedures. 
There was no personal or family history of skin cancer. 
A 7 mm hyperpigmented bluish papule was observed on the 
posterior right thigh. On dermoscopy the lesion showed a conti-
nuous blue-gray blotch of pigment with no other visible structures. 
The lesion was promptly excised. Histopathology showed a 
circumscribed, symmetrical, wedge-shaped dermal proliferation 
composed predominantly of pigmented epithelioid cells and den-
dritic cells. The cells had large nuclei and prominent nucleoli. In 
some areas multinucleated cells were found. No mitotic figures 
were identified.
The clinical and histological findings were compatible with PEM.
DISCUSSION
Sentinel lymph node (SLN) involvement observed in the majori-
ty of PEMs6 along with the tumor once being categorized as an "ani-
mal-type" melanoma2 prompted most previous reports to include 
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SLN sampling as a diagnostic procedure.  However, the frequent 
SLN involvement in PEMs does not have the same adverse prognos-
tic significance as in conventional melanoma2,6-8 and the positive 
rate in cases undergoing SNLB  may be over-estimated due to a 
more progressive clinical course or deeper tumor cell invasion.9
Another theory is that PEMs may be part of the neoplasms 
known as "benign metastasizing” tumors.8 These particular kinds of 
tumors include both cutaneous and non-cutaneous lesions such as 
benign melanocytic naevi, endometriosis and metastasizing leio-
myomas.8
Additionally, based on current studies, a positive sentinel lymph 
node sampling appears to present little important evidence of the 
lesion's biological potential and its risk of developing clinically 
significant metastatic disease.10 Taking that into consideration it 
can be argued that SLN sampling should not be performed in every 
patient with PEM.8
There are no clearly established criteria for performing SLNB 
in PEM patients9 and no histological criteria predictive of potential 
metastatic behavior of the tumor.2,10 Current studies suggest that 
PEM is an indolent melanocytic tumor and long-term follow-ups 
have not revealed disease-specific lethal cases regardless of tumor 
deposits in sentinel lymph node sampling.1
Sentinel lymph node sampling was not performed in this case 
due to lack of evidence proving diagnostic or prognostic value of 
this practice on this kind of tumor.1 A complementary wide surgi-
cal excision was performed and the patient will go through a long 
follow-up period. 
In conclusion, while it is considered to be an indolent tumor, 
PEM patients should undergo a long follow-up period and further 
studies are needed on whether SLNB should be performed as a 
staging procedure in every case of PEM. 
Figure 1 - Dermoscopy image of the lesion showing a continuous 
blue-gray blotch of pigment. 
Figure 3 - Pigmented epithelioid and dendritic cells with large nuclei 
and prominent nucleoli (H&E x400). 
Figure 2 - Symmetrical, wedge-shaped dermal proliferation com-
posed predominantly of pigmented epithelioid and dendritic cells 
(H&E x100).
Figure 4 - In some areas multinucleated cells were found (H&E x400).
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